Can We Live to 200?

In the last century, the average human life expectancy doubled. Here’s a roadmap to the innovations that could help us do it again — maybe.

By Nicholas St. Fleur, Chloe Williams and Charlie Wood

The New York Times looks at interventions to address aging. We are the only commercially available product on the market with data showing a positive effect on healthspan and lifespan. The first suggestion in the article references the work we’ve done with Rejuvant.